Wealth Management Associates, Inc.

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 2067339 Cherry Hill, NJ

Position in NAMS

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$239,093

New position

Shares Held

7,055

first reported quarter

Ownership

0.006%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#154

of 197 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Wealth Management Associates, Inc. holds $2,766,947 across 5 Biotechnology names. NAMS ranks #5 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	10,754	$800,957
2	ABUS	Arbutus Biopharma Corp	147,995	$710,376
3	IBRX	ImmunityBio, Inc.	69,325	$606,940
4	RVMD	Revolution Medicines, Inc.	2,187	$409,581
5	NAMS	NewAmsterdam Pharma Co N.V. This page	7,055	$239,093

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$239,093	7,055	—	Shares	Sole	2026-07-21
No filing history on record for this holder in this stock.